Epistra

Case Studies

Case Studies

Track Record

Industry-Leading Track Record Extensive experience across life science fields

19 cases
Productivity Improvement
12 cases
Quality Improvement
15 cases
Material Cost Reduction
16 cases
R&D Period Reduction

More Cases

Additional Case Studies

  1. Biopharmaceuticals

    Cell Culture Media Development for Antibody Drug Manufacturing

    • 40% Improvement in Antibody Production

    Using CellTune, our culture optimization software powered by Epistra Accelerate, we improved the feed media composition for antibody production. As a result of the optimization, we discovered a media composition that increased antibody production by approximately 40% compared to the pre-optimization composition.

    Cell Culture Media Development for Antibody Drug Manufacturing
  2. Assay Development

    Novel Assay System Construction

    • 46% Improvement in Detection Sensitivity
    • 44% Reduction in R&D Period

    We optimized conditions for a novel assay for drug screening. Human researchers and Epistra Accelerate independently conducted the optimization and compared results. The conditions discovered by Epistra Accelerate improved pre-optimization sensitivity by 46% and exceeded human-discovered conditions by 12%. While human researchers took 4.5 months, Epistra Accelerate completed the exploration in 2.5 months, achieving a 44% reduction in R&D time.

    Novel Assay System Construction
  3. Cryopreservation

    Improving Cell Preservation Reagent Performance

    • 133% Improvement in Yield
    • 40% Improvement in Functionality
    • Robust Against Temperature/Concentration Changes

    We developed a higher-performance cell preservation reagent for the commercialization of cell-based therapeutics. Through optimization, we identified a reagent composition that improved yield by 133% and cell functionality by 40% compared to commercially available products. The identified composition is also robust against temperature and concentration variations, while avoiding third-party intellectual property.

    Improving Cell Preservation Reagent Performance
  4. Cell Therapy

    Culture Media Cost Reduction

    • 70% Cost Reduction

    Culture media costs for pharmaceutical manufacturing are high. We undertook an initiative to minimize media costs while maintaining comparable performance to improve profitability. Through optimization, we achieved a 70% reduction in total media costs, with projected ongoing savings of over 400 million yen per year.

    Culture Media Cost Reduction
  5. Cell Therapy

    Animal Origin-Free (AOF) Medium Development

    • Significant Yield Improvement
    • Achieved AOF

    We optimized the media composition for the client's mesenchymal stem cells (MSC) using Epistra Accelerate. After 4 months of condition screening, we discovered a media composition with superior proliferative capacity and significantly reduced raw material costs. All media developed in this project are animal origin-free (AOF), containing no animal or human-derived factors.

    Animal Origin-Free (AOF) Medium Development

Applications

Applicable to a Wide Range of Use Cases

  • Antibody Drugs
  • Cryopreservation Solutions
  • Chemically Defined Media
  • Regenerative Medicine
  • Bio-manufacturing
  • Vaccine Manufacturing
  • Breeding
  • Assay Development

Contact

Get in Touch

We work closely with our clients, providing optimal solutions tailored to their needs. Feel free to reach out.

Contact Us